Hikma Pharmaceuticals PLC (HKMPF)

Market Cap	4.82B
Revenue (ttm)	3.22B
Net Income (ttm)	371.00M
Shares Out	n/a
EPS (ttm)	1.67
PE Ratio	12.99
Forward PE	9.19
Dividend	0.84 (3.83%)
Ex-Dividend Date	Aug 14, 2025

Volume	406
Average Volume	1,522
Open	22.00
Previous Close	22.37
Day's Range	21.94 - 22.00
52-Week Range	21.94 - 28.92
Beta	0.60
RSI	36.90
Earnings Date	Nov 7, 2025

About Hikma Pharmaceuticals

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Generics segment offers oral, respiratory, and other generic and specialty products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1978
• Employees: 9,500
• Stock Exchange: OTCMKTS
• Ticker Symbol: HKMPF

Financial Performance

In 2024, Hikma Pharmaceuticals's revenue was $3.13 billion, an increase of 8.77% compared to the previous year's $2.88 billion. Earnings were $359.00 million, an increase of 88.95%.